Results 31 to 40 of about 1,302,625 (339)

Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Vaccines, 2021
The current study systematically reviewed, summarized and meta-analyzed the clinical features of the vaccines in clinical trials to provide a better estimate of their efficacy, side effects and immunogenicity.
A. Pormohammad, M. Zarei, S. Ghorbani, M Mohammadi, Razizadeh Mh, Turner Rj   +5 more
semanticscholar   +1 more source

Acknowledgement to Reviewers of Vaccines in 2017

Vaccines, 2018
Peer review is an essential part in the publication process, ensuring that Vaccines maintains high quality standards for its published papers.[...]
Vaccines Editorial Office
doaj   +1 more source

Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines

Vaccines, 2021
COVID-19 vaccines have been developed with unprecedented speed which would not have been possible without decades of fundamental research on delivery nanotechnology.
T. H. Thi, Estelle J A Suys, J. S. Lee, D. Nguyen, K. Park, N. Truong   +5 more
semanticscholar   +1 more source

Varicella: to vaccinate or not to vaccinate? [PDF]

Archives of Disease in Childhood, 1998
Editor,—I am in complete agreement with Dr Aebi that strategies for delivering varicella vaccine effectively are critical to the success of immunisation programmes.1 In the USA great efforts are being made in this direction. Nevertheless, despite the licensure of varicella vaccine for routine use in the United …
openaire   +5 more sources

Acknowledgement to Reviewers of Vaccines in 2013

Vaccines, 2014
The editors of Vaccines would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2013.
Vaccines Editorial Office
doaj   +1 more source

COVID-19 vaccines: where we stand and challenges ahead

Cell Death and Differentiation, 2021
In the eleven months elapsed since the identification of the SARS-CoV-2 virus and its genome, an exceptional effort by the scientific community has led to the development of over 300 vaccine projects.
Guido Forni, Alberto Mantovani, Guido Alberto Lorenzo Rino Giovanni Arnaldo Giuseppina G Forni Mantovani Moretta Rappuoli Rezza Bagnasco Ba, Guido Forni, Alberto Mantovani, L. Moretta, R. Rappuoli, G. Rezza, A. Bagnasco, G. Barsacchi, Giovanni Bussolati, Massimo Cacciari, P. Cappuccinelli, Enzo Cheli, Renato Guarini, M. Bacci, Marco Mancini, Cristina Marcuzzo, M. Morrone, Giorgio Parisi, G. Pasquino, C. Patrono, A. Curzio, G. Remuzzi, Alessando Roncaglia, S. Schiaffino, Paolo Vineis   +26 more
semanticscholar   +1 more source

Acknowledgement to Reviewers of Vaccines in 2015

Vaccines, 2016
The editors of Vaccines would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2015. [...]
Vaccines Editorial Office
doaj   +1 more source

Acknowledgement to Reviewers of Vaccines in 2018

Vaccines, 2019
Rigorous peer-review is the corner-stone of high-quality academic publishing. [...]
Vaccines Editorial Office
doaj   +1 more source

Causal inference concepts applied to three observational studies in the context of vaccine development: from theory to practice

BMC Medical Research Methodology, 2021
Background Randomized controlled trials are considered the gold standard to evaluate causal associations, whereas assessing causality in observational studies is challenging.
Emilia Gvozdenović, Lucio Malvisi, Elisa Cinconze, Stijn Vansteelandt, Phoebe Nakanwagi, Emmanuel Aris, Dominique Rosillon   +6 more
doaj   +1 more source

COVID-19 vaccines: modes of immune activation and future challenges

Nature reviews. Immunology, 2021
The new vaccines against SARS-CoV-2 are novel in terms of specificity, their wide dissemination across the global population and the inclusion of newly licensed mRNA platforms.
J. Teijaro, D. Farber
semanticscholar   +1 more source